Transoral robotic surgery: A population-level analysis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 150, Issue 6, 2014, Pages 968-975

  Chen, Michelle M ^a   Roman, Sanziana A ^b   Kraus, Dennis H ^c   Sosa, Julie A ^b   Judson, Benjamin L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New York Head & Neck Institute   (United States)

Author keywords

Adjuvant therapy; Margins; National Cancer Data Base; Oropharyngeal cancer; Transoral robotic surgery; Unplanned readmission

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH INSURANCE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ORAL SURGERY; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; ROBOTICS; TRANSORAL ROBOTIC SURGERY; WART VIRUS; FACTUAL DATABASE; HOSPITALIZATION; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; ROBOTIC SURGICAL PROCEDURE; STATISTICS AND NUMERICAL DATA; SURGICAL MARGIN; TREATMENT OUTCOME; UNITED STATES; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; DEMOGRAPHY; HUMAN TISSUE; INTERMETHOD COMPARISON; OROPHARYNX CANCER; POSTOPERATIVE PERIOD; SQUAMOUS CELL CARCINOMA;

ADULT; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MARGINS OF EXCISION; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; ROBOTIC SURGICAL PROCEDURES; TREATMENT OUTCOME; UNITED STATES;

EID: 84903516905     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814525747     Document Type: Article

References (22)

1. Park YM, Lee WJ, Lee JG, et al. Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A. 2009;19:361-368.
2. Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. Int J Radiat Oncol. 2013;85:1163-1167.
3. Weinstein GS, O'Malley BW Jr., Desai SC, Quon H. Transoral robotic surgery: does the end justify the means? Curr Opin Otolaryngol Head Neck Surg. 2009;17:126-131.
4. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119:2156-2164.
5. Boudreaux BA, Rosenthal EL, Magnuson JS, et al. Robotassisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Neck Surg. 2009;135:397.
6. Weinstein GS, O'Malley BW Jr., Snyder W, Sherman E, Quon H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Neck Surg. 2007;133:1220.
7. Yu H, Friedlander DF, Patel S, Hu JC. The current status of robotic oncologic surgery. CA Cancer J Clin. 2013;63:45-56.
8. Blanco RGF, Fakhry C, Ha PK, et al. Transoral robotic surgery experience in 44 cases. J Laparoendosc Adv Surg Tech A. 2013;23:900-907.
9. White H, Ford S, Bush B, et al. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Neck Surg. 2013;139:773-778.
10. Phillips J, Eremin D, Stewart A. National Cancer Data Base online data dictionary, beta-test (2011). http://ncdbpuf.facs .org/?q=node/259. Accessed October 8, 2013.
11. Winchester DP, Stewart AK, Phillips JL, Ward EE. The National Cancer Data Base: past, present, and future. Ann Surg Oncol. 2010;17:4-7.
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
13. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed.New York, NY: Springer; 2010.
14. White HN, Frederick J, Zimmerman T, Carroll WR, Magnuson J. Learning curve for transoral robotic surgery: a 4-year analysis. JAMA Otolaryngol Neck Surg. 2013;139:564-567.
15. Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller R-P, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncol. 2007;43:402-407.
16. Machtay M, Perch S, Markiewicz D, et al. Combined surgery and postoperative radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognostic value of margin status. Head Neck. 1997;19;494-9.
17. Haughey BH, Hinni ML, Salassa JR, et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33:1683-1694.
18. Weinstein GS, O'Malley BW, Magnuson JS, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope. 2012;122:1701-1707.
19. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
20. O'Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013;31:543-550.
21. Quon H, Forastiere AA. Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? J Clin Oncol. 2013;31:520-522.
22. Holsinger FC. Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based IMRT and weekly cisplatin versus IMRT and weekly cisplatin for HPV negative oropharynx cancer. http://www.rtog.org/ ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1221. Published October 2, 2013. Accessed November 15, 2013.